Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. Jun 15, 2024; 16(6): 2463-2475
Published online Jun 15, 2024. doi: 10.4251/wjgo.v16.i6.2463
Published online Jun 15, 2024. doi: 10.4251/wjgo.v16.i6.2463
Table 2 Comparison of positive rates of biomarkers
| HCC (n = 180) | AFP (-) (n = 86) | Healthy (n = 100) | P value | |
| GP73 | < 0.001 | |||
| Positive rate | 80 (144/180) | 75.6 (65/86) | 7 (7/100) | |
| Negative rate | 20 (36/180) | 24.4 (21/86) | 93 (93/100) | |
| DCP | < 0.001 | |||
| Positive rate | 70 (126/180) | 72.1 (62/86) | 29 (29/100) | |
| Negative rate | 30 (54/180) | 21.4 (24/86) | 71 (71/100) | |
| CK18-M65 | < 0.001 | |||
| Positive rate | 87.8 (158/180) | 87.2 (75/86) | 6 (6/100) | |
| Negative rate | 12.2 (22/180) | 12.8 (11/86) | 94 (94/100) | |
| CK18-M30 | < 0.001 | |||
| Positive rate | 79.4 (143/180) | 73.3 (63/86) | 12 (12/100) | |
| Negative rate | 20.6 (37/180) | 26.7 (23/86) | 88 (88/100) | |
- Citation: He L, Zhang C, Liu LL, Huang LP, Lu WJ, Zhang YY, Zou DY, Wang YF, Zhang Q, Yang XL. Development of a diagnostic nomogram for alpha-fetoprotein-negative hepatocellular carcinoma based on serological biomarkers. World J Gastrointest Oncol 2024; 16(6): 2463-2475
- URL: https://www.wjgnet.com/1948-5204/full/v16/i6/2463.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i6.2463